R&D expense · 2011–2025
Arrowhead Pharmaceuticals R&D expense
$607M+20.0% · FY2025
Arrowhead Pharmaceuticals (ARWR) reported $607M in R&D expense for fiscal 2025, +20.0% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-09-30 | $607M | +20.0% | Open → |
| FY20242024-09-30 | $506M | +43.2% | Open → |
| FY20232023-09-30 | $353M | +18.8% | Open → |
| FY20222022-09-30 | $297M | +44.1% | Open → |
| FY20212021-09-30 | $206M | +60.1% | Open → |
| FY20202020-09-30 | $129M | +59.0% | Open → |
| FY20192019-09-30 | $81.0M | +53.0% | Open → |
| FY20182018-09-30 | $53.0M | +4.1% | Open → |
| FY20172017-09-30 | $50.9M | −18.1% | Open → |
| FY20162016-09-30 | $62.1M | +31.4% | Open → |
| FY20152015-09-30 | $47.3M | +104.3% | Open → |
| FY20142014-09-30 | $23.1M | +165.8% | Open → |
| FY20132013-09-30 | $8.7M | +61.5% | Open → |
| FY20122012-09-30 | $5.4M | +64.5% | Open → |
| FY20112011-09-30 | $3.3M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +45.2%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arrowhead Pharmaceuticals R&D expense |url=https://companiesranked.com/en/company/arrowhead-pharmaceuticals/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arrowhead Pharmaceuticals R&D expense. CompaniesRanked. https://companiesranked.com/en/company/arrowhead-pharmaceuticals/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-arrowhead-pharmaceuticals-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Arrowhead Pharmaceuticals R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arrowhead-pharmaceuticals/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.